Nurturing a supportive 
payer environment

Identifying the access policy imperatives most important to our client's portfolios, and helping them build compelling evidence, credible payer proposals, and stakeholder engagement to drive positive change within existing frameworks.

Connect with our Experts

How we can support

Sustainable access to innovation in rare diseases and oncology hinges on having the right policy and payer frameworks.

Meaningful impact requires thought leadership – we believe that industry needs to proactively shape the policy debate, not only react to it.

At Prescient, we help our clients identify the access policy imperatives most important to their portfolios. We generate compelling evidence, develop credible payer proposals, and engage with stakeholders to drive positive change or flexibility within existing decision-making frameworks.


Our Market Access Pricing services

The numbers

Deep expertise

0

+ Projects delivered

Influential outputs

0

+ Papers published

Impactful engagement

0

+ Stakeholder events executed

News and Insights

Explore our latest insights, whitepapers, and event highlights to learn more about the latest developments and perspectives shaping the evolving healthcare landscape.

Discover all
Whitepaper

ONWARD Driving equitable access and system readiness in cancer care 

Find out more
Whitepaper

Getting comparators right to support access to rare disease medicines 

Find out more
Whitepaper

Taiwan Perspectives from the ONWARD Initiative: Advancing Equitable Access and System Readiness in Cancer Care

Find out more
Whitepaper

Why Orphan Medicines remain out of reach in low- and middle-income countries – and what can be done 

Find out more
Whitepaper

Future-Proofing HTA: the case for flexibility in assessment frameworks

Find out more

Wondering how Prescient can help you shape P&R frameworks?

If you’re interested in learning more about our services or would like to speak with the team, please get in touch.

Connect with our experts